A malignant phenotype of hypertrophic cardiomyopathy caused by Arg719Gln cardiac beta-myosin heavy-chain mutation in a Chinese family

被引:10
作者
Huang, XH
Song, L
Ma, AQ
Gao, JH
Zheng, WY
Zhou, XL
Zhang, Q
Liu, YL
Hu, RT
机构
[1] Chinese Acad Med Sci, Fu Wai Cardiovasc Hosp & Cardiovasc Inst, Sino German Lab Mol Med, Beijing 100037, Peoples R China
[2] Chinese Acad Med Sci, Fu Wai Cardiovasc Hosp & Cardiovasc Inst, Dept Echocardiog, Beijing 100037, Peoples R China
[3] Xian Jiaotong Univ, Hosp 1, Dept Cardiol, Xian, Peoples R China
关键词
hypertrophic cardiomyopathy; gene mutation; beta-myosin heavy chain; polymerase chain reaction; single-strand conformation polymorphism;
D O I
10.1016/S0009-8981(01)00538-1
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Mutations of the cardiac P-myosin heavy-chain (D-MHC) gene cause hypertrophic cardiomyopathy (HCM). Recent genotype-phenotype correlation studies have shown that mutations carry prognostic significance. We studied five unrelated Chinese families with hypertrophic cardiomyopathy. Exons 3-27 and 40 of the beta -MHC gene were screened with both the polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) method and the cycle sequencing of the PCR products. A previously reported heterozygous mutation Arg719Gln (arginine --> glutamine in codon 719) in exon 19 was found in one family. The proband is a 30-year-old female diagnosed at age of 25 years when she presented with symptoms of chest pain, palpitations, and frequent incidents of dizziness and syncope. A two-dimensional echocardiogram showed moderate asymmetrical septal hypertrophy with left atrial enlargement. There was no obstruction of the left ventricular outflow tract (LVOT). The patient also developed atrial fibrillation. The proband's mother and one of her sisters had similar clinical manifestations and both died suddenly at the age of 38 years. In addition, two silent nucleotide substitutions (ACT63ACC, TTT244TTC) in the cardiac beta -MHC gene were identified in the other four families. These synonymous mutations did not cosegregate with the disease in the families and they were also present in the 60 healthy and age-matched control subjects. Of the five families studied, we did not find any missense mutation in the remaining four families. The missense mutation Arg719Gln found in the Chinese family is associated with a malignant phenotype of severe symptoms and poor survival prognosis. This mutation also causes atrial enlargement and atrial fibrillation. Our study clinical provides further evidence that the mutation, which alters the charge of the myosin heavy chain, is associated with a serious clinical outcome. (C) 2001 Elsevier Science BN. All rights reserved.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 36 条
[1]   PROGNOSTIC IMPLICATIONS OF NOVEL BETA-CARDIAC MYOSIN HEAVY-CHAIN GENE-MUTATIONS THAT CAUSE FAMILIAL HYPERTROPHIC CARDIOMYOPATHY [J].
ANAN, R ;
GREVE, G ;
THIERFELDER, L ;
WATKINS, H ;
MCKENNA, WJ ;
SOLOMON, S ;
VECCHIO, C ;
SHONO, H ;
NAKAO, S ;
TANAKA, H ;
MARES, A ;
TOWBIN, JA ;
SPIRITO, P ;
ROBERTS, R ;
SEIDMAN, JG ;
SEIDMAN, CE .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01) :280-285
[2]   CARDIAC MYOSIN BINDING PROTEIN-C GENE SPLICE ACCEPTOR SITE MUTATION IS ASSOCIATED WITH FAMILIAL HYPERTROPHIC CARDIOMYOPATHY [J].
BONNE, G ;
CARRIER, L ;
BERCOVICI, J ;
CRUAUD, C ;
RICHARD, P ;
HAINQUE, B ;
GAUTEL, M ;
LABEIT, S ;
JAMES, M ;
BECKMANN, J ;
WEISSENBACH, J ;
VOSBERG, HP ;
FISZMAN, M ;
KOMAJDA, M ;
SCHWARTZ, K .
NATURE GENETICS, 1995, 11 (04) :438-440
[3]   FAMILIAL PREVALENCE AND GENETIC TRANSMISSION OF IDIOPATHIC HYPERTROPHIC SUBAORTIC STENOSIS [J].
CLARK, CE ;
HENRY, WL ;
EPSTEIN, SE .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (14) :709-714
[4]   A NEW MISSENSE MUTATION, ARG719GLN, IN THE BETA-CARDIAC HEAVY-CHAIN MYOSIN GENE OF PATIENTS WITH FAMILIAL HYPERTROPHIC CARDIOMYOPATHY [J].
CONSEVAGE, MW ;
SALADA, GC ;
BAYLEN, BG ;
LADDA, RL ;
ROGAN, PK .
HUMAN MOLECULAR GENETICS, 1994, 3 (06) :1025-1026
[5]   DIFFERENCES IN CLINICAL EXPRESSION OF HYPERTROPHIC CARDIOMYOPATHY ASSOCIATED WITH 2 DISTINCT MUTATIONS IN THE BETA-MYOSIN HEAVY-CHAIN GENE - A 908LEU-]VAL MUTATION AND A 403ARG-]GLN MUTATION [J].
EPSTEIN, ND ;
COHN, GM ;
CYRAN, F ;
FANANAPAZIR, L .
CIRCULATION, 1992, 86 (02) :345-352
[6]   EVIDENCE OF GENETIC-HETEROGENEITY IN 5 KINDREDS WITH FAMILIAL HYPERTROPHIC CARDIOMYOPATHY [J].
EPSTEIN, ND ;
FANANAPAZIR, L ;
LIN, HJ ;
MULVIHILL, J ;
WHITE, R ;
LALOUEL, JM ;
LIFTON, RP ;
NIENHUIS, AW ;
LEPPERT, M .
CIRCULATION, 1992, 85 (02) :635-647
[7]   GENOTYPE-PHENOTYPE CORRELATIONS IN HYPERTROPHIC CARDIOMYOPATHY - INSIGHTS PROVIDED BY COMPARISONS OF KINDREDS WITH DISTINCT AND IDENTICAL BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS [J].
FANANAPAZIR, L ;
EPSTEIN, ND .
CIRCULATION, 1994, 89 (01) :22-32
[8]   Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy [J].
Forissier, JF ;
Carrier, L ;
Farza, H ;
Bonne, G ;
Bercovici, J ;
Richard, P ;
Hainque, B ;
Townsend, PJ ;
Yacoub, MH ;
Faure, S ;
Dubourg, O ;
Millaire, A ;
Hagege, AA ;
Desnos, M ;
Komajda, M ;
Schwartz, K .
CIRCULATION, 1996, 94 (12) :3069-3073
[9]   A MOLECULAR-BASIS FOR FAMILIAL HYPERTROPHIC CARDIOMYOPATHY - A BETA-CARDIAC MYOSIN HEAVY-CHAIN GENE MISSENSE MUTATION [J].
GEISTERFERLOWRANCE, AAT ;
KASS, S ;
TANIGAWA, G ;
VOSBERG, HP ;
MCKENNA, W ;
SEIDMAN, CE ;
SEIDMAN, JG .
CELL, 1990, 62 (05) :999-1006
[10]  
GLANCY DL, 1970, BRIT HEART J, V32, P652